PT  - JOURNAL ARTICLE
AU  - Melanie Nana
AU  - Catherine Nelson-Piercy
TI  - COVID-19 in pregnancy
AID  - 10.7861/clinmed.2021-0503
DP  - 2021 Sep 01
TA  - Clinical Medicine
PG  - e446--e450
VI  - 21
IP  - 5
4099  - http://www.rcpjournals.org/content/21/5/e446.short
4100  - http://www.rcpjournals.org/content/21/5/e446.full
SO  - Clin Med2021 Sep 01; 21
AB  - Pregnant women with COVID-19 are less likely to be symptomatic than non-pregnant counterparts. Risk factors for severe disease include being overweight or obese, greater than 35 years old, and having pre-existing comorbidities. Those who develop severe disease have increased rates of admission to an intensive care unit, requiring invasive ventilation and pre-term birth.Pregnant and breastfeeding women with COVID-19 should be investigated as of outside pregnancy and should receive proven therapies (such as corticosteroids and tocilizumab) on a risk/benefit basis. Admitted women should receive multidisciplinary care with input from senior decision makers and early escalation where required. There are no safety concerns ­surrounding the COVID-19 vaccination and fertility or pregnancy, and so it should be offered to women based on their age and clinical risk group, in line with non-pregnant women.